{"entity":{"type":"insider","cik":"0001451612","url":"/insider/0001451612","json_url":"/insider/0001451612.json","name":"Booth Bruce","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":287,"n_filings":33,"first":"2018-02-13","last":"2026-07-02","span_basis":"filed_date"},"name_variants":[{"name":"Booth Bruce","source":"filing","n_filings":33,"first_seen":"2018-02-13","last_seen":"2026-07-02"}],"transactions":[{"id":9289069,"accession":"0001451612-26-000022","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001451612-26-000022","line_url":"/filing/0001451612-26-000022","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76650.0,"shares_display":"76,650","price_per_share":108.04833163731246,"price_display":"108.05","price_state":"stated","total_value":8281904.62,"total_display":"8,281,904.62","total_whole":"8,281,905","shares_owned_after":462986.0,"shares_owned_after_display":"462,986","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-07-02","scope":"insider","n_lines":14},{"id":5823776,"accession":"0001451612-26-000020","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001451612-26-000020","line_url":"/filing/0001451612-26-000020","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31283.0,"shares_display":"31,283","price_per_share":109.47800242943451,"price_display":"109.48","price_state":"stated","total_value":3424800.35,"total_display":"3,424,800.35","total_whole":"3,424,800","shares_owned_after":2402089.0,"shares_owned_after_display":"2,402,089","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-06-30","scope":"insider","n_lines":8},{"id":5812797,"accession":"0001451612-26-000018","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45367.0,"shares_display":"45,367","price_per_share":107.06249630788899,"price_display":"107.06","price_state":"stated","total_value":4857104.27,"total_display":"4,857,104.27","total_whole":"4,857,104","shares_owned_after":2412747.0,"shares_owned_after_display":"2,412,747","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-06-30","scope":"insider","n_lines":6},{"id":5812787,"accession":"0001451612-26-000018","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-24","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":231007.0,"shares_display":"231,007","price_per_share":108.14,"price_display":"108.14","price_state":"stated","total_value":24981096.98,"total_display":"24,981,096.98","total_whole":"24,981,097","shares_owned_after":2603048.0,"shares_owned_after_display":"2,603,048","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812785,"accession":"0001451612-26-000018","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-23","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32624.0,"shares_display":"32,624","price_per_share":109.79,"price_display":"109.79","price_state":"stated","total_value":3581788.96,"total_display":"3,581,788.96","total_whole":"3,581,789","shares_owned_after":2570424.0,"shares_owned_after_display":"2,570,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812784,"accession":"0001451612-26-000018","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-22","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32402.0,"shares_display":"32,402","price_per_share":108.14,"price_display":"108.14","price_state":"stated","total_value":3503952.28,"total_display":"3,503,952.28","total_whole":"3,503,952","shares_owned_after":493358.0,"shares_owned_after_display":"493,358","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812782,"accession":"0001451612-26-000018","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-21","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28296.0,"shares_display":"28,296","price_per_share":107.57,"price_display":"107.57","price_state":"stated","total_value":3043800.72,"total_display":"3,043,800.72","total_whole":"3,043,801","shares_owned_after":2834055.0,"shares_owned_after_display":"2,834,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812781,"accession":"0001451612-26-000018","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-20","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27951.0,"shares_display":"27,951","price_per_share":114.94,"price_display":"114.94","price_state":"stated","total_value":3212687.94,"total_display":"3,212,687.94","total_whole":"3,212,688","shares_owned_after":2505362.0,"shares_owned_after_display":"2,505,362","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812779,"accession":"0001451612-26-000018","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-19","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22046.0,"shares_display":"22,046","price_per_share":117.85,"price_display":"117.85","price_state":"stated","total_value":2598121.1,"total_display":"2,598,121.10","total_whole":"2,598,121","shares_owned_after":2464314.0,"shares_owned_after_display":"2,464,314","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812775,"accession":"0001451612-26-000018","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-18","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14913.0,"shares_display":"14,913","price_per_share":113.97,"price_display":"113.97","price_state":"stated","total_value":1699634.61,"total_display":"1,699,634.61","total_whole":"1,699,635","shares_owned_after":2533313.0,"shares_owned_after_display":"2,533,313","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812772,"accession":"0001451612-26-000018","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-17","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12390.0,"shares_display":"12,390","price_per_share":118.66,"price_display":"118.66","price_state":"stated","total_value":1470197.4,"total_display":"1,470,197.40","total_whole":"1,470,197","shares_owned_after":2451924.0,"shares_owned_after_display":"2,451,924","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812770,"accession":"0001451612-26-000018","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-16","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12181.0,"shares_display":"12,181","price_per_share":117.09,"price_display":"117.09","price_state":"stated","total_value":1426273.29,"total_display":"1,426,273.29","total_whole":"1,426,273","shares_owned_after":2486360.0,"shares_owned_after_display":"2,486,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812769,"accession":"0001451612-26-000018","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-15","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11277.0,"shares_display":"11,277","price_per_share":110.49,"price_display":"110.49","price_state":"stated","total_value":1245995.73,"total_display":"1,245,995.73","total_whole":"1,245,996","shares_owned_after":2559147.0,"shares_owned_after_display":"2,559,147","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812767,"accession":"0001451612-26-000018","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-14","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10366.0,"shares_display":"10,366","price_per_share":111.51,"price_display":"111.51","price_state":"stated","total_value":1155912.66,"total_display":"1,155,912.66","total_whole":"1,155,913","shares_owned_after":2548781.0,"shares_owned_after_display":"2,548,781","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812765,"accession":"0001451612-26-000018","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-13","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6821.0,"shares_display":"6,821","price_per_share":115.69,"price_display":"115.69","price_state":"stated","total_value":789121.49,"total_display":"789,121.49","total_whole":"789,121","shares_owned_after":2498541.0,"shares_owned_after_display":"2,498,541","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812764,"accession":"0001451612-26-000018","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-12","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4562.0,"shares_display":"4,562","price_per_share":109.79,"price_display":"109.79","price_state":"stated","total_value":500861.98,"total_display":"500,861.98","total_whole":"500,862","shares_owned_after":488796.0,"shares_owned_after_display":"488,796","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812762,"accession":"0001451612-26-000018","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-11","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3958.0,"shares_display":"3,958","price_per_share":107.57,"price_display":"107.57","price_state":"stated","total_value":425762.06,"total_display":"425,762.06","total_whole":"425,762","shares_owned_after":525760.0,"shares_owned_after_display":"525,760","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812760,"accession":"0001451612-26-000018","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-10","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3896.0,"shares_display":"3,896","price_per_share":114.94,"price_display":"114.94","price_state":"stated","total_value":447806.24,"total_display":"447,806.24","total_whole":"447,806","shares_owned_after":479718.0,"shares_owned_after_display":"479,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812759,"accession":"0001451612-26-000018","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-9","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3069.0,"shares_display":"3,069","price_per_share":117.85,"price_display":"117.85","price_state":"stated","total_value":361681.65,"total_display":"361,681.65","total_whole":"361,682","shares_owned_after":473996.0,"shares_owned_after_display":"473,996","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812757,"accession":"0001451612-26-000018","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-8","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2083.0,"shares_display":"2,083","price_per_share":113.97,"price_display":"113.97","price_state":"stated","total_value":237399.51,"total_display":"237,399.51","total_whole":"237,400","shares_owned_after":483614.0,"shares_owned_after_display":"483,614","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812756,"accession":"0001451612-26-000018","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-7","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1729.0,"shares_display":"1,729","price_per_share":118.66,"price_display":"118.66","price_state":"stated","total_value":205163.14,"total_display":"205,163.14","total_whole":"205,163","shares_owned_after":472267.0,"shares_owned_after_display":"472,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812754,"accession":"0001451612-26-000018","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-6","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1701.0,"shares_display":"1,701","price_per_share":117.09,"price_display":"117.09","price_state":"stated","total_value":199170.09,"total_display":"199,170.09","total_whole":"199,170","shares_owned_after":477065.0,"shares_owned_after_display":"477,065","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812752,"accession":"0001451612-26-000018","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-5","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1579.0,"shares_display":"1,579","price_per_share":110.49,"price_display":"110.49","price_state":"stated","total_value":174463.71,"total_display":"174,463.71","total_whole":"174,464","shares_owned_after":487217.0,"shares_owned_after_display":"487,217","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812749,"accession":"0001451612-26-000018","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-4","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1442.0,"shares_display":"1,442","price_per_share":111.51,"price_display":"111.51","price_state":"stated","total_value":160797.42,"total_display":"160,797.42","total_whole":"160,797","shares_owned_after":485775.0,"shares_owned_after_display":"485,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5812748,"accession":"0001451612-26-000018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001451612-26-000018","line_url":"/filing/0001451612-26-000018#line-3","is_derivative":false,"issuer_cik":"0001451612","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001451612","owner_cik":"0001451612","owner_name":"Booth Bruce","owner_display_name":"Booth Bruce","owner_url":"/insider/0001451612","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":952.0,"shares_display":"952","price_per_share":115.69,"price_display":"115.69","price_state":"stated","total_value":110136.88,"total_display":"110,136.88","total_whole":"110,137","shares_owned_after":478766.0,"shares_owned_after_display":"478,766","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"}],"collapsed":true,"next_cursor":"2026-06-26|5812748","ledger_fault":false,"count":{"value":287,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":281,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":287},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001815442","name":"Kymera Therapeutics, Inc.","url":"/issuer/0001815442","role":"Director","n_filings":21,"first_seen":"2021-03-16","last_seen":"2026-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0002036042","name":"Sionna Therapeutics, Inc.","url":"/issuer/0002036042","role":"Director","n_filings":6,"first_seen":"2025-02-10","last_seen":"2025-10-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001827087","name":"Vigil Neuroscience, Inc.","url":"/issuer/0001827087","role":"Director","n_filings":1,"first_seen":"2022-01-11","last_seen":"2022-01-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001690585","name":"Magenta Therapeutics, Inc.","url":"/issuer/0001690585","role":"Director","n_filings":2,"first_seen":"2019-03-22","last_seen":"2020-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001681087","name":"AVROBIO, Inc.","url":"/issuer/0001681087","role":"Director","n_filings":1,"first_seen":"2019-07-23","last_seen":"2019-07-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001622229","name":"Unum Therapeutics Inc.","url":"/issuer/0001622229","role":"Director","n_filings":1,"first_seen":"2018-04-03","last_seen":"2018-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001590750","name":"MIRAGEN THERAPEUTICS, INC.","url":"/issuer/0001590750","role":"Director","n_filings":1,"first_seen":"2018-02-13","last_seen":"2018-02-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001451612","retrieved_at":"2026-08-22T16:47:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}